THE NEGLECTED TROPICAL DISEASES GROUP / RARE DISEASES GROUP / Neglected Diseases Group / /
Event
FDA Phase / Product Issues / /
IndustryTerm
review / prevention of rare diseases / biological3 products / review groups / contaminated food / therapeutics for rare genetic diseases / biological drug products / orphan products / therapeutics for rare diseases / Treatment of Rare and Neglected Diseases / biotechnology product development / treatment of rare diseases / therapies for rare diseases / medical products / biological device products / Therapeutics for Rare and Neglected Diseases / biologic medical products / treatment of neglected diseases / device applications / orphan drug products / /
MedicalCondition
rare diseases / individual diseases / rare cancers / rare genetic diseases / Huntington’s disease / orphan disease / serious diseases / disease / generally infectious diseases / neglected diseases / rare disease / less serious diseases / EXAMPLES OF MEDICAL PRODUCTS APPROVED FOR RARE DISEASES / serious and life-threatening diseases / diseases / each disease / tropical diseases / tropical disease / /
MedicalTreatment
treatment protocols / /
Organization
National Institute of Health / Food and Drug Administration / Institute of Medicine / FDA’s office of Orphan Products Development / Department of Health and Human Services Food and Drug Administration / Congress / Federal government / office of Rare Diseases Research / Center for Devices and Radiologic Health / Center for Drug Evaluation and Research / Center for Biologics Evaluation and Research / /
Position
Commissioner / /
Product
ntd / RARE DISEASES / scientific foundation / FDA / water / food / core knowledge vital / /
Report to Congress: Improving the Prevention, Diagnosis, and Treatment of Rare and Neglected Diseases